Home » Topics » Conferences

Conferences
RSS

Bayer evaluates novel heteroaryl oxazolidinones

Sep. 30, 1997

New class of antifungal agents developed at Glaxo Wellcome

Sep. 30, 1997

LF-08-0299 both prevents and reverses kidney rejection in dogs

Sep. 30, 1997

LY-333334: new bone anabolic agent from Lilly

Sep. 30, 1997

PathoGenesis presents new antimycobacterial agents

Sep. 30, 1997

Pentoxifylline demonstrates gastroprotective effects in patient study

Sep. 30, 1997

Clinical pharmacokinetics and bradycardic activity of S-16257

Sep. 30, 1997

Clinical results presented for Knoll's PEG-hirudin

Sep. 30, 1997

Clinical pharmacokinetics and safety reported for Sankyo's MAO-A inhibitor

Sep. 30, 1997

Oral and nasal sumatriptan studied for migraine

Sep. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...